In his blog, My thoughts on the future of infectious disease and medicine, Infectious disease physician, Steven LaRosa, MD writes in one post of 21 infectious disease “pearls” or teaching points concerning treatment and diagnosis of infections.
During this interview, I ask Dr. LaRosa to expand on several of them (from the use of Vancomycin to the treatment and interpretation of laboratory results for Babesiosis) in a very informative discussion.
Check out his blog at My thoughts on the future of infectious disease and medicine
- What’s happened to Zika? Is the outbreak in the Americas over?
- Travel health and medicine issues
- Healthcare-associated infections: A discussion with Dr Rodney Rohde
- Vaccine refusal: What’s behind it and how we become better ambassadors for vaccination
- The story behind the Toxic Shock Syndrome outbreak investigation of the late 70s-early 80s
- Cholera: The disease, the Yemen crisis and the vaccine
- Vaccines: How they work and some common misconceptions
- Everything you wanted to know about rabies
- Powassan virus: The spread is inevitable
- Lyme: Q & A with Paul Auwaerter, MD
- Antibiotics: Skin infections and the FDA approval of Baxdela
- New antibiotic, closthioamide, effective against gonorrhea in laboratory studies: London researchers
- New treatment for drug-resistant gonorrhea, Zoliflodacin, to enter global Phase 3 clinical trial
- Lab Week 2017: A discussion panel